Balance Sheet

Assets

+11%

-12%

10Y

Currency: CNY

	Dec-2001	Dec-2002	Dec-2003	Dec-2004	Dec-2005	Dec-2006	Dec-2007	Dec-2008	Dec-2009	Dec-2010	Dec-2011	Dec-2012	Dec-2013	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023	Dec-2024
Assets
Cash & Cash Equivalents	3	44	47	5	8	18	42	49	233	249	287	217	225	152	261	341	125	100	51	46	87	136	202	272
Cash	0	0	0	0	0	0	0	0	0	0	0	14	103	51	45	0	0	0	0	0	87	136	202	272
Cash Equivalents	3	44	47	5	8	18	42	49	233	249	287	204	122	101	216	341	125	100	51	46	0	0	0	0
Short-Term Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	10	6	0	0	40	45	10	0	0	0	0
Total Receivables	14	136	251	193	9	8	13	14	125	204	209	139	266	221	303	131	114	249	259	184	175	208	224	208
Accounts Receivables	3	119	231	170	1	2	1	1	57	50	69	78	100	95	142	119	105	231	235	170	163	197	214	192
Other Receivables	12	17	20	24	7	6	12	14	68	154	139	61	166	126	161	11	9	17	24	14	12	11	10	16
Inventory	35	100	93	66	2	1	1	1	129	182	171	317	337	226	196	217	273	221	237	188	194	149	125	100
Other Current Assets	1	5	47	12	0	0	9	35	234	194	138	191	128	97	66	19	15	12	7	12	12	12	14	3
Total Current Assets	53	286	438	276	18	27	64	99	721	829	804	863	956	705	831	708	527	621	599	441	468	506	565	583
PP&E Net	240	256	274	269	216	58	58	94	1 956	2 498	2 856	2 808	2 832	2 621	2 524	166	193	210	205	182	164	148	138	140
PP&E Gross	240	256	274	269	216	58	58	94	1 956	2 498	2 856	2 808	2 832	2 621	2 524	166	193	210	205	182	164	148	138	140
Accumulated Depreciation	54	50	55	62	101	17	12	14	167	238	349	521	680	669	832	40	55	75	96	121	144	167	185	196
Intangible Assets	11	23	22	21	9	3	445	445	552	560	557	554	551	548	403	19	17	16	14	13	12	12	21	36
Goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1 704	1 081	173	156	12	11	11	11	11
Long-Term Investments	5	15	15	16	43	172	171	170	170	181	181	183	185	188	168	174	202	213	298	309	308	305	309	309
Other Long-Term Assets	4	6	5	4	4	7	5	6	8	8	12	10	17	104	136	13	12	16	20	19	20	19	18	35
Other Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1 704	1 081	173	156	12	11	11	11	11
Total Assets	313 N/A	586 +87%	754 +29%	586 -22%	290 -50%	266 -8%	742 +179%	813 +10%	3 407 +319%	4 077 +20%	4 410 +8%	4 418 +0%	4 540 +3%	4 166 -8%	4 063 -2%	2 784 -31%	2 033 -27%	1 248 -39%	1 291 +3%	975 -25%	982 +1%	1 001 +2%	1 062 +6%	1 115 +5%
Liabilities
Accounts Payable	7	33	11	52	6	4	3	8	103	129	163	212	256	275	420	15	31	73	41	50	58	93	101	87
Accrued Liabilities	14	24	61	93	99	64	262	266	245	356	612	80	62	56	88	15	20	27	31	26	29	32	35	35
Short-Term Debt	78	263	354	186	79	68	19	7	186	670	721	875	778	813	269	57	14	0	58	133	75	63	54	4
Current Portion of Long-Term Debt	73	74	81	27	27	37	0	0	0	120	0	227	288	313	186	4	5	5	0	0	0	1	0	0
Other Current Liabilities	9	9	13	8	66	6	8	8	80	159	221	823	993	1 030	2 129	326	186	183	142	99	92	102	118	183
Total Current Liabilities	179	403	520	367	277	179	292	289	613	1 435	1 717	2 216	2 377	2 486	3 092	417	255	289	271	308	254	289	308	309
Long-Term Debt	11	4	4	0	10	0	0	0	1 148	935	1 172	740	440	210	76	22	17	12	0	0	0	2	1	0
Deferred Income Tax	0	0	0	0	0	0	2	4	5	8	10	13	15	17	19	24	23	24	31	34	37	39	42	44
Minority Interest	3	56	88	74	2	3	88	89	234	191	174	163	386	258	122	13	12	6	0	5	5	0	0	0
Other Liabilities	0	0	0	0	0	61	111	176	670	650	412	346	338	455	421	22	4	4	35	8	5	4	4	3
Total Liabilities	194 N/A	463 +139%	612 +32%	442 -28%	286 -35%	243 -15%	493 +103%	557 +13%	2 670 +379%	3 219 +21%	3 486 +8%	3 477 0%	3 555 +2%	3 427 -4%	3 730 +9%	498 -87%	311 -38%	335 +8%	337 +1%	355 +6%	301 -15%	334 +11%	355 +6%	356 +0%
Equity
Common Stock	95	95	95	95	95	95	142	142	142	269	269	269	269	269	249	400	400	400	400	375	375	378	382	384
Retained Earnings	147	144	127	136	96	96	71	64	46	0	66	83	83	151	557	438	1 002	1 810	1 643	1 978	1 918	1 953	1 940	1 898
Additional Paid In Capital	172	172	174	186	24	25	178	178	641	589	589	589	633	621	641	2 322	2 322	2 322	2 322	2 214	2 217	2 235	2 258	2 266
Unrealized Security Profit/Loss	0	0	0	0	18	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8	7	7	7
Treasury Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	133	0	0	0	0	0
Other Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	8	8	0	0	0	0
Total Equity	120 N/A	123 +3%	142 +15%	144 +2%	5 -97%	23 +402%	249 +978%	256 +3%	737 +188%	858 +16%	924 +8%	942 +2%	985 +5%	739 -25%	333 -55%	2 286 +586%	1 722 -25%	914 -47%	955 +4%	619 -35%	681 +10%	667 -2%	707 +6%	759 +7%
Total Liabilities & Equity	313 N/A	586 +87%	754 +29%	586 -22%	290 -50%	266 -8%	742 +179%	813 +10%	3 407 +319%	4 077 +20%	4 410 +8%	4 418 +0%	4 540 +3%	4 166 -8%	4 063 -2%	2 784 -31%	2 033 -27%	1 248 -39%	1 291 +3%	975 -25%	982 +1%	1 001 +2%	1 062 +6%	1 115 +5%
Shares Outstanding
Common Shares Outstanding	95	95	95	95	95	95	142	142	142	269	269	269	269	269	249	400	400	400	400	375	375	378	382	384

Income Statement Balance Sheet Cash Flow Statement

Xinjiang Bai Hua Cun Pharma Tech Co Ltd
SSE:600721

Balance Sheet

Balance Sheet Decomposition
Xinjiang Bai Hua Cun Pharma Tech Co Ltd

Balance Sheet
Xinjiang Bai Hua Cun Pharma Tech Co Ltd

See Also

Company

Help

Tools

Stocks

Xinjiang Bai Hua Cun Pharma Tech Co Ltd SSE:600721

Balance Sheet

Balance Sheet Decomposition Xinjiang Bai Hua Cun Pharma Tech Co Ltd

Balance Sheet Xinjiang Bai Hua Cun Pharma Tech Co Ltd

See Also

Company

Help

Tools

Stocks

Xinjiang Bai Hua Cun Pharma Tech Co Ltd
SSE:600721

Balance Sheet Decomposition
Xinjiang Bai Hua Cun Pharma Tech Co Ltd

Balance Sheet
Xinjiang Bai Hua Cun Pharma Tech Co Ltd